跳到正文
FDA 官方药品与生物制品信息·· 7 小时前AI 评分23

FDA 非处方药(OTC)监管页面:CARES Act 与 OTC 专论改革

Over-the-Counter (OTC) | Nonprescription Drugs

AI 导读

美国 FDA 发布非处方药(OTC)监管信息页面,说明消费者无需处方即可安全有效使用 OTC 药品,涵盖咳嗽感冒药、退烧药、防晒霜、止痛药、抗酸药等。页面同时介绍 FDA 对 OTC 药品的监管方式,并指出 2020 年 3 月 27 日签署成为法律的《冠状病毒援助、救济和经济安全法案》(CARES Act)包含规范并现代化美国部分 OTC 药品监管方式的条款。

正文 · 原文

Nonprescription (or over-the-counter) drugs are available to consumers without a prescription. They can be safely and effectively used without the supervision of a healthcare provider. Nonprescription drugs have long provided an efficient, accessible way for Americans to manage everyday health needs and they play an increasingly vital role in our healthcare system. The vast array of nonprescription drugs include cough and cold medications, fever reducers, sunscreens, pain relievers, antacids, and many more. 

This page describes how FDA regulates nonprescription drugs and offers resources to the public. Consumers seeking general information about the safe use of nonprescription drugs may visit our consumer website.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act includes provisions that governs and modernizes the way certain over-the-counter (OTC) drugs are regulated in the United States. Learn more about the CARES Act and OTC monograph reform.

来源:FDA 官方药品与生物制品信息 · fda.gov